Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011.
Identifieur interne : 000216 ( Main/Exploration ); précédent : 000215; suivant : 000217Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011.
Auteurs : Anne Hackenberg [Allemagne] ; Gökhan Arman-Kalcek ; Jens Hiller ; Gülsah GabrielSource :
- Medical microbiology and immunology [ 1432-1831 ] ; 2013.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Allemagne (épidémiologie), Anticorps antiviraux (sang), Facteurs de l'âge, Femelle, Grippe humaine (immunologie), Grippe humaine (épidémiologie), Humains, Jeune adulte, Mâle, Sous-type H1N1 du virus de la grippe A (immunologie), Sujet âgé, Études séroépidémiologiques.
- MESH :
- immunologie : Grippe humaine, Sous-type H1N1 du virus de la grippe A.
- sang : Anticorps antiviraux.
- épidémiologie : Allemagne, Grippe humaine.
- Adolescent, Adulte, Adulte d'âge moyen, Facteurs de l'âge, Femelle, Humains, Jeune adulte, Mâle, Sujet âgé, Études séroépidémiologiques.
- Wicri :
- geographic : Allemagne.
English descriptors
- KwdEn :
- MESH :
- chemical , blood : Antibodies, Viral.
- geographic , epidemiology : Germany.
- epidemiology : Influenza, Human.
- immunology : Influenza A Virus, H1N1 Subtype, Influenza, Human.
- Adolescent, Adult, Age Factors, Aged, Female, Humans, Male, Middle Aged, Seroepidemiologic Studies, Young Adult.
Abstract
Location- and age-specific prevalence of antibodies against 2009 pandemic influenza A (H1N1) virus were determined in sera of blood donors collected during winter 2010/2011 in Germany. Prevalence of antibodies at protective titres (HI ≥1:40) varied significantly between cities (24.13-83.67 %) throughout all age groups. However, high level antibodies (HI >1:80) were most prevalent among young individuals (18-29 and 30-39 years). Overall, this study demonstrates that older people (50-59 and 60-70 years) are no longer more likely to present protective antibody titres against 2009 pandemic influenza A (H1N1) virus than younger individuals. Furthermore, our data show a highly variable immunity among the German population in different major cities almost 2 years after the detection of first cases in Germany.
DOI: 10.1007/s00430-012-0251-4
PubMed: 22684725
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011.</title>
<author><name sortKey="Hackenberg, Anne" sort="Hackenberg, Anne" uniqKey="Hackenberg A" first="Anne" last="Hackenberg">Anne Hackenberg</name>
<affiliation wicri:level="3"><nlm:affiliation>Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg</wicri:regionArea>
<placeName><settlement type="city">Hambourg</settlement>
<region type="land" nuts="2">Hambourg</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Arman Kalcek, Gokhan" sort="Arman Kalcek, Gokhan" uniqKey="Arman Kalcek G" first="Gökhan" last="Arman-Kalcek">Gökhan Arman-Kalcek</name>
</author>
<author><name sortKey="Hiller, Jens" sort="Hiller, Jens" uniqKey="Hiller J" first="Jens" last="Hiller">Jens Hiller</name>
</author>
<author><name sortKey="Gabriel, Gulsah" sort="Gabriel, Gulsah" uniqKey="Gabriel G" first="Gülsah" last="Gabriel">Gülsah Gabriel</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:22684725</idno>
<idno type="pmid">22684725</idno>
<idno type="doi">10.1007/s00430-012-0251-4</idno>
<idno type="wicri:Area/Main/Corpus">000236</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000236</idno>
<idno type="wicri:Area/Main/Curation">000236</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000236</idno>
<idno type="wicri:Area/Main/Exploration">000236</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011.</title>
<author><name sortKey="Hackenberg, Anne" sort="Hackenberg, Anne" uniqKey="Hackenberg A" first="Anne" last="Hackenberg">Anne Hackenberg</name>
<affiliation wicri:level="3"><nlm:affiliation>Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg</wicri:regionArea>
<placeName><settlement type="city">Hambourg</settlement>
<region type="land" nuts="2">Hambourg</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Arman Kalcek, Gokhan" sort="Arman Kalcek, Gokhan" uniqKey="Arman Kalcek G" first="Gökhan" last="Arman-Kalcek">Gökhan Arman-Kalcek</name>
</author>
<author><name sortKey="Hiller, Jens" sort="Hiller, Jens" uniqKey="Hiller J" first="Jens" last="Hiller">Jens Hiller</name>
</author>
<author><name sortKey="Gabriel, Gulsah" sort="Gabriel, Gulsah" uniqKey="Gabriel G" first="Gülsah" last="Gabriel">Gülsah Gabriel</name>
</author>
</analytic>
<series><title level="j">Medical microbiology and immunology</title>
<idno type="eISSN">1432-1831</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Antibodies, Viral (blood)</term>
<term>Female</term>
<term>Germany (epidemiology)</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (immunology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Seroepidemiologic Studies</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Allemagne (épidémiologie)</term>
<term>Anticorps antiviraux (sang)</term>
<term>Facteurs de l'âge</term>
<term>Femelle</term>
<term>Grippe humaine (immunologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Sujet âgé</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Germany</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Allemagne</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Seroepidemiologic Studies</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Facteurs de l'âge</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Sujet âgé</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Location- and age-specific prevalence of antibodies against 2009 pandemic influenza A (H1N1) virus were determined in sera of blood donors collected during winter 2010/2011 in Germany. Prevalence of antibodies at protective titres (HI ≥1:40) varied significantly between cities (24.13-83.67 %) throughout all age groups. However, high level antibodies (HI >1:80) were most prevalent among young individuals (18-29 and 30-39 years). Overall, this study demonstrates that older people (50-59 and 60-70 years) are no longer more likely to present protective antibody titres against 2009 pandemic influenza A (H1N1) virus than younger individuals. Furthermore, our data show a highly variable immunity among the German population in different major cities almost 2 years after the detection of first cases in Germany.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22684725</PMID>
<DateCompleted><Year>2013</Year>
<Month>07</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1831</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>202</Volume>
<Issue>1</Issue>
<PubDate><Year>2013</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Medical microbiology and immunology</Title>
<ISOAbbreviation>Med. Microbiol. Immunol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011.</ArticleTitle>
<Pagination><MedlinePgn>87-94</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s00430-012-0251-4</ELocationID>
<Abstract><AbstractText>Location- and age-specific prevalence of antibodies against 2009 pandemic influenza A (H1N1) virus were determined in sera of blood donors collected during winter 2010/2011 in Germany. Prevalence of antibodies at protective titres (HI ≥1:40) varied significantly between cities (24.13-83.67 %) throughout all age groups. However, high level antibodies (HI >1:80) were most prevalent among young individuals (18-29 and 30-39 years). Overall, this study demonstrates that older people (50-59 and 60-70 years) are no longer more likely to present protective antibody titres against 2009 pandemic influenza A (H1N1) virus than younger individuals. Furthermore, our data show a highly variable immunity among the German population in different major cities almost 2 years after the detection of first cases in Germany.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hackenberg</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Arman-Kalcek</LastName>
<ForeName>Gökhan</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hiller</LastName>
<ForeName>Jens</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gabriel</LastName>
<ForeName>Gülsah</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2012</Year>
<Month>06</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Med Microbiol Immunol</MedlineTA>
<NlmUniqueID>0314524</NlmUniqueID>
<ISSNLinking>0300-8584</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year>
<Month>12</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2012</Year>
<Month>05</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>6</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>6</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2013</Year>
<Month>7</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">22684725</ArticleId>
<ArticleId IdType="doi">10.1007/s00430-012-0251-4</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>PLoS One. 2010 Sep 07;5(9):e12562</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20830210</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2011 Mar 10;471(7337):157-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21390107</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2012 Feb;18(2):177-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21635661</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2010 Apr 14;303(14):1383-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20388894</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2011 May 23;29(23):4008-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21463683</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1467-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22065279</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2010 Dec 09;15(49):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21163179</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2011;6(9):e23955</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21915270</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Microbiol Immunol. 2010 May;199(2):117-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20162304</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2009 Jun;58(6):446-58</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19446340</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Commun. 2011 Jan 18;2:156</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21245837</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2009 Jun 19;324(5934):1557-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19433588</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2010 Sep;82(9):1617-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20648619</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2010 Mar 27;375(9720):1100-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20096450</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2009 Jul 10;325(5937):197-201</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19465683</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2010 Jan;48(1):290-1</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19889892</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2011 Feb 09;6(2):e16809</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21347418</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19745214</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2010 Oct 07;15(40):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20946757</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2010 Dec 16;15(50):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21172169</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2010 Jun 17;15(24):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20576237</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Vaccine Immunol. 2011 Aug;18(8):1205-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21653743</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2010 Jul 29;15(30):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20684814</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2012 Jan 12;17(2):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22264864</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2010 Nov 15;51(10):1184-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20964521</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Infect Dis. 2010 Jun 07;10:155</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20525408</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infection. 2011 Apr;39(2):101-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21424756</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
</country>
<region><li>Hambourg</li>
</region>
<settlement><li>Hambourg</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Arman Kalcek, Gokhan" sort="Arman Kalcek, Gokhan" uniqKey="Arman Kalcek G" first="Gökhan" last="Arman-Kalcek">Gökhan Arman-Kalcek</name>
<name sortKey="Gabriel, Gulsah" sort="Gabriel, Gulsah" uniqKey="Gabriel G" first="Gülsah" last="Gabriel">Gülsah Gabriel</name>
<name sortKey="Hiller, Jens" sort="Hiller, Jens" uniqKey="Hiller J" first="Jens" last="Hiller">Jens Hiller</name>
</noCountry>
<country name="Allemagne"><region name="Hambourg"><name sortKey="Hackenberg, Anne" sort="Hackenberg, Anne" uniqKey="Hackenberg A" first="Anne" last="Hackenberg">Anne Hackenberg</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000216 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000216 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= GrippeAllemagneV3 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:22684725 |texte= Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22684725" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a GrippeAllemagneV3
This area was generated with Dilib version V0.6.35. |